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Introduction
The sodium channel is essential for generation and propagation of action potentials [1] . In skeletal muscle, the predominant isoform, Nav1.4, is encoded by SCN4A and is responsible for >90% of the sodium current in muscle fibres [2] . SCN4A mutations yield a broad range of phenotypes depending on the underlying pathophysiology. Dominant mutations usually lead to a gain of function of the Nav1.4 sodium channel, resulting in congenital myotonia or periodic paralysis, collectively known as sodium channelopathies [3] . These mutations in SCN4A can result in sustained muscle contraction, causing myotonia, or a prolonged refractory state with fast inactivation of the channel, yielding a periodic paralysis phenotype [4, 5] . In rare cases recessive loss of function SCN4A mutations have been shown to cause a congenital myasthenic syndrome [3, 6] . Recently, Zaharieva et al. (2016) described a spectrum of phenotypes ranging from severe foetal hypokinesia to congenital myopathy, associated with loss of function of the channel due to recessive mutations in SCN4A in 11 patients from six unrelated families. Muscle biopsies of their patients were non-specific and there were no distinct features indicative of a specific subtype of congenital myopathy. Muscle MRI in a subset of these patients revealed a consistent pattern, with predominant involvement of the gluteus maximus, adductor magnus, sartorius, and soleus muscles [7] . We describe two siblings with loss of function of the Nav1.4 channel due to compound heterozygous mutations in SCNA4 and features of congenital myopathy with "corona" fibres on muscle biopsy.
Case presentation
Two siblings, aged 21 (Sibling 1) and 18 (Sibling 2), were born to non-consanguineous parents of East Indian background ( Fig. 1 ). Written informed consent was obtained from both subjects to participate in this study.
Sibling 1 was born at term following a normal pregnancy. Hypotonia was noted at birth, but he achieved all motor milestones on time. He started walking at 14 months of age, but his parents noticed that he tended to fall and trip often and he had weakness of the proximal muscles of the lower limbs. He had motor difficulties which impaired daily living. There was no history of fluctuating or fatigable weakness, seizures, swallowing difficulties, myotonia, cardiac symptoms, rhabdomyolysis or migraine.
On physical exam, he had a highly arched palate, distal joint hypermobility, bilateral gynecomastia (surgically corrected), mild scoliosis and pectus excavatum. 
Methods

Molecular Genetics
Exome capture was carried out using the Agilent SureSelect Clinical Research Exome target enrichment kit from 3µg of genomic DNA using the Bravo Automated Liquid Handling Platform 
Mutagenesis, HEK293 cell transfection
The expression clone carrying the human SCN4A insert was a gift from SC Cannon (University of Texas Southwestern Medical Center, Dallas, USA). Site directed mutagenesis was performed using the QuikChange kit (Agilent technologies) and successful mutagenesis was confirmed by sequencing the entire insert. HEK293 cells were transfected with 0.5 μg of wild type or mutant plasmid and 50 ng of plasmid coding for cop-GFP using Lipofectamine 2000 (Thermofisher) in a 1.9 cm 2 well. 
Results
Muscle Biopsy
H&E staining of the right quadriceps from Sibling 2 revealed significant fatty replacement and fibrosis involving the perimysium with no inflammation or vasculitis. The muscle fibres showed mild variation in fibre size, and the majority of muscle fibres had multiple internalized nuclei.
These nuclei showed a distinctive arrangement, being located away from the sarcolemma, and surrounding a central core-like structure. The nuclei have the appearance of a "crown", or "corona", with the central area of core-like disorganization within the fibres representing a head of hair, surrounded by a crown of nuclei. (Fig. 2A) .
Frozen section slides stained with ATPase (4.2 and 9.6) showed predominance of type I fibers.
There was no evidence of grouping, or selective fibre type atrophy or degeneration. Areas of clearly defined central pallor were observed in both types of fibers (Fig. 2D ). Further stains for oxidative enzymes (NADH-TR, COX and SDH) highlighted the absence of oxidative enzyme activity at the center of these myofibres (Fig. 2B ). There were no enzyme aggregates or COXdeficient fibres. Gomori trichrome staining showed no evidence of ragged red fibres; however the cores of the affected fibres were highlighted as intense dark green aggregates (Fig. 2C ). PAS and Oil red O stains were normal. Desmin staining revealed desmin-positive aggregates and preferential labeling of the "crown" with the antibody (Fig. 2E ).
Electron microscopy studies showed myofibrillar disarray predominantly located at the centre of affected fibres and rarely peripherally located. These core-like structures are encircled/rimmed by multiple nuclei within a single myofibre. Mitochondria and other organelles were seen clustering toward the periphery of the fibres, beyond the nuclear rim ( Fig. 2F ). Other fibres showed only myofibrillar disarray. The sarcolemma was preserved with no evidence of duplication, and there were no nemaline rods or deposits. The mitochondria showed normal subsarcolemmal peripheral aggregation, with preserved shape and size. No abnormal glycogen accumulation was seen. The blood vessels were normal with no evidence of tubuloreticular inclusions.
Exome sequencing
Both affected siblings were found to be compound heterozygous for c.3425G>A (p.Arg1142Gln) and c.1123T>C (p.Cys375Arg) mutations in SCN4A (NM_000334.4) on exome sequencing, and the parents were confirmed carriers ( Fig.1M-N) . All exons of DNM2 and MTM1 were well covered, with each base pair of the coding regions sequenced to at least 20X, and no pathogenic variants were found in either of these genes.
Functional studies
Patch clamp data are summarized in Fig. 3A-E . HEK293 cells transfected with DNA coding for p.Cys375Arg channel did not show any sodium currents (n=14). Both wild type and p.Arg1142Gln channels conduct sodium currents. The voltage dependence of activation was shifted to depolarizing direction for p.Arg1142Gln channels by ~4 mV (p<0.01). This results in reduced peak current densities for the p.Arg1142Gln channels at voltages just above activation threshold. Fast inactivation properties of p.Arg1142Gln channels were also mildly attenuated: voltage dependence of fast inactivation was shifted in the depolarizing direction with an increase in the slope factor, the recovery from inactivation was accelerated and time course of inactivation at 0 mV was slower (all p<0.05). The time course of closed state inactivation and voltage dependence of slow inactivation were unaffected.
Discussion
Recessive loss-of -function mutations of Nav1.4 are rare and usually associated with a more severe phenotype than dominant gain of function mutations. Recessive mutations of SCN4A causing loss of function have been associated with rare cases of congenital myasthenic syndrome [3, 6] . Recessive mutations which completely abolish channel function were reported to cause a neonatal lethal condition, however the combination of full and partial loss of function mutations were associated with a classical congenital myopathy phenotype [7] . Here we describe two siblings with a compound heterozygous c.3425G>A (p.Arg1142Gln) and c.1123T>C (p.Cys375Arg) mutations in SCN4A. The p.Cys375Arg mutation is located in the extracellular loop between the S5 and S6 helices in domain I of NaV1.4, whereas p.Arg1142Gln is located in the S4 voltage sensor helix of domain III (Fig. 3F) . Consistent with the reported congenital myopathy cases [7] we found that one of the variants, p.Cys375Arg, caused full loss of function, while the variant in the second allele, p.Arg1142Gln, caused partial loss of function. The loss of function properties of the p.Arg1142Gln are mild compared to the congenital myopathy NaV1.4 variants described previously (four mV shift in the voltage dependence of activation). This may explain the comparatively mild clinical phenotype in our patients. We also describe unusual muscle pathology associated with mutations in SCN4A. The muscle biopsy for Sibling 2 has features reminiscent of necklace fibres, previously described only in centronuclear myopathies [8] [9] [10] [11] . However, the muscle pathology we describe differs from the classic necklace fibres reported initially by Bevilacqua et.al. (2009) as electron microscopy revealed core-like structures encircled by morphologically normal nuclei. The pattern of clustering of the nuclei had the appearance of a "crown", with the central area of core-like myofibrillar disarray within the fibres representing a head of hair, surrounded by a crown of nuclei. Therefore, we propose designating them "corona" fibres to facilitate recognition of this novel neuropathologic feature. It is worth noting that the core-like lesions observed in our patient are similar to those described in patients with RYR1 mutations, an important calcium channel also reported to cause centronuclear myopathy [12, 13] .
In conclusion, we report two new novel mutations in SCN4A associated with unusual muscle biopsy features, skeletal abnormalities and distinct pattern of involvement on muscle MRI. This expands the phenotypes associated with SCN4A mutations to include congenital "corona" myopathy. Arg1142Gln channels in response to voltage steps ranging from -100 mV to 50 mV in 10 mV increments from holding voltage of -80 mV. The voltage protocol is shown in insert. The arrows point the current trace in response to voltage step to -20 mV. The wild type current amplitude at -20 mV is closer to the maximal current amplitude compared to p.Arg1142Gln channels. No currents were detected in cells transfected with vector coding for p.Cys375Arg. Scale bars are 0.5 ms (x-axis) and 0.5 nA (y-axis). (B) Mean peak current density of wild type (solid square), p.Cys375Arg (solid circle) and p.Arg1142Gln (open circles) channels is plotted against the test voltage, measured using voltage protocol in G. Asterisks next to the p.Arg1142Gln symbols indicate the voltages at which the current density of the R1142Q channels was statistically significantly (Student's t-test) lower for R1142Q than for wild type channels. N(WT)=15, n(p.Cys375Arg)=14, n(p.Arg1142Gln)=18. Dashed line indicates zero current level. (C). Voltage dependence of activation is shifted in depolarizing direction for p.Arg1142Gln channels compared to wild type channels. Voltage protocol is as in A. The conductance is plotted against the test voltage and fitted with Boltzmann function. The voltage at which half of the p.Arg1142Gln channels are active (-16.7±0.7 m V, n=18) is significantly different (p<0.01) from that of wild-type channels (-20.4±0.9 mV, n=15). The slope factors did not differ. Solid line shows the Boltzmann fit to mean wild type data, dashed line to mean p.Arg1142Gln data. (D). Voltage dependence of fast inactivation is shifted in depolarizing direction for p.Arg1142Gln channels compared to wild type channels. The voltage protocol is shown in insert. A pre-pulse voltage step of 150 ms ranging from -150 mV to
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